Stay updated on Oral Enzalutamide in Advanced Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Oral Enzalutamide in Advanced Prostate Cancer Clinical Trial page.

Latest updates to the Oral Enzalutamide in Advanced Prostate Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov website as revision v3.8.0 instead of v3.7.2.SummaryDifference0.0%

- Check19 days agoChange DetectedA site-wide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference0.4%

- Check26 days agoChange DetectedThe ClinicalTrials.gov footer now displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check33 days agoChange DetectedThe ClinicalTrials.gov footer site revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision entry labeled v3.7.0 was added to the study record history, replacing the previous v3.6.6.SummaryDifference0.1%

- Check75 days agoChange DetectedAn updated Revision: v3.6.6 has been added to the list of changes, replacing Revision: v3.6.5. This reflects a metadata update to the record.SummaryDifference0.1%

Stay in the know with updates to Oral Enzalutamide in Advanced Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Enzalutamide in Advanced Prostate Cancer Clinical Trial page.